News Home

Should Drug Manufacturers - General Stock AbbVie Inc (ABBV) Be in Your Portfolio Monday?

Monday, April 01, 2024 01:24 PM | InvestorsObserver Analysts

Mentioned in this article

Should Drug Manufacturers - General Stock AbbVie Inc (ABBV) Be in Your Portfolio Monday?

The 63 rating InvestorsObserver gives to AbbVie Inc (ABBV) stock puts it near the top of the Drug Manufacturers - General industry. In addition to scoring higher than 92 percent of stocks in the Drug Manufacturers - General industry, ABBV’s 63 overall rating means the stock scores better than 63 percent of all stocks.

Overall Score - 63
ABBV has an Overall Score of 63. Find out what this means to you and get the rest of the rankings on ABBV!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 63 means the stock is more attractive than 63 percent of stocks.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With AbbVie Inc Stock Today?

AbbVie Inc (ABBV) stock is trading at $179.91 as of 1:17 PM on Monday, Apr 1, a decline of -$2.20, or -1.21% from the previous closing price of $182.10. The stock has traded between $179.24 and $181.90 so far today. Volume today is below average. So far 1,354,954 shares have traded compared to average volume of 5,986,465 shares. Click Here to get the full Stock Report for AbbVie Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App